Brief: Adocia Announces Positive Topline Data From Study Of Biochaperone

Adocia SA

25/01/2018 17:01

Jan 25 (Reuters) - Adocia Sa  ADOC.PA : 
    * ADOCIA ANNOUNCES POSITIVE TOPLINE DATA FROM A 
DOSE-PROPORTIONALITY STUDY OF BIOCHAPERONE COMBO IN PEOPLE WITH 
TYPE 2 DIABETES 
    * ADOCIA SA - STUDY CONFIRMED PREVIOUS RESULTS THAT 
BIOCHAPERONE 
COMBO ACTS SIGNIFICANTLY FASTER AND LASTS SIGNIFICANTLY LONGER 
THAN HUMALOGMIX 
    * ADOCIA SA - ALL TREATMENTS WERE WELL TOLERATED 
    * ADOCIA SA - BOTH PRIMARY ENDPOINTS WERE MET IN STUDY 
 
Source text for Eikon:  ID:nBw3FxjpNa  
Further company coverage:  ADOC.PA  
 
 ((Bangalore.newsroom@thomsonreuters.com;))